Orion Porfolio Solutions LLC Acquires 5,867 Shares of Cardinal Health, Inc. $CAH

Orion Porfolio Solutions LLC raised its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 11.0% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 59,357 shares of the company’s stock after purchasing an additional 5,867 shares during the period. Orion Porfolio Solutions LLC’s holdings in Cardinal Health were worth $9,972,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of CAH. Norges Bank bought a new position in shares of Cardinal Health in the second quarter worth about $584,420,000. Wellington Management Group LLP lifted its stake in shares of Cardinal Health by 1,666.7% in the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock valued at $328,470,000 after purchasing an additional 2,249,241 shares during the last quarter. Zurich Insurance Group Ltd FI raised its stake in shares of Cardinal Health by 4,935.9% in the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock valued at $130,434,000 after acquiring an additional 927,950 shares during the period. Acadian Asset Management LLC boosted its position in shares of Cardinal Health by 92.5% during the second quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock valued at $282,063,000 after buying an additional 807,063 shares during the period. Finally, T. Rowe Price Investment Management Inc. bought a new position in Cardinal Health in the 1st quarter valued at $104,951,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Down 0.2%

Shares of NYSE:CAH opened at $198.01 on Monday. Cardinal Health, Inc. has a 52-week low of $114.60 and a 52-week high of $214.93. The stock has a market cap of $47.05 billion, a price-to-earnings ratio of 29.87, a PEG ratio of 1.44 and a beta of 0.63. The business has a 50-day moving average price of $186.76 and a 200-day moving average price of $166.80.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping the consensus estimate of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The company had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. During the same quarter in the prior year, the company earned $1.88 EPS. Cardinal Health’s quarterly revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, equities analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is currently 30.77%.

Analyst Ratings Changes

A number of analysts recently issued reports on CAH shares. Wells Fargo & Company boosted their price target on Cardinal Health from $185.00 to $221.00 and gave the company an “overweight” rating in a report on Wednesday, November 5th. TD Cowen increased their target price on shares of Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, November 3rd. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a research note on Tuesday, November 18th. Barclays initiated coverage on Cardinal Health in a research note on Monday, December 8th. They issued an “overweight” rating and a $243.00 target price on the stock. Finally, Robert W. Baird set a $232.00 price target on shares of Cardinal Health in a report on Friday, October 31st. Thirteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $209.00.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.